404
Chronic Low Back Pain Treatment Market Report
Global Chronic Low Back Pain Treatment Marke, Trends, Forecast & Market Analysis
The Global Chronic Low Back Pain Treatment Market is segmented By Treatment Type (Analgesic Medication, Nonsteroidal Anti-inflammatory Drugs, Anticonvulsants, Antidepressants, Others), By End Use (Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Others), and Region. ...
The chronic low back pain treatment market size is expected to reach USD 9.78 billion in the foreseeable future.
Johnson & Johnson Services Inc. (The U.S.), Pfizer Inc. (The U.S.), Sanofi (France), Endo Pharmaceuticals Inc. (Ireland), Merck & Co., Inc. (The U.S.), Vertebral Technologies, Inc. (The U.S.), Medtronic (Ireland), Boston Scientific Corporation (The U.S.), Braeburn Pharmaceuticals (The U.S.), and Camurus (Sweden) are among the key players in the chronic low back pain treatment market.
The chronic low back pain treatment market is expected to witness an impressive growth of 4.9% CAGR in the coming years.
An upsurge in the occurrence of nerve cases, rising growth in the geriatric population, growing healthcare awareness among developed and emerging countries, inactive lifestyles, and growing purchasing power of consumers are the factors driving the growth of chronic low back pain treatment market.
North American market accounted for the largest market share in 2020 and is projected to grow at a steady CAGR during the forecast period.
Analgesic medication segment dominated the market in 2020 and is projected to register a healthy CAGR during the assessment period.
Chronic low back pain treatment companies, Hospitals, R&D centers, Pharmaceutical companies, Orthopedic Clinics are the target audience in the chronic low back pain treatment market.